RMD Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Community Narratives
Narratives bring a range of perspectives from our community.
Revolutionizing Sleep Health, Wearables, Digital Innovation, And Global Expansion Propel Growth
ResMed Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$245.02 |
52 Week High | US$246.80 |
52 Week Low | US$132.24 |
Beta | 0.66 |
11 Month Change | 9.56% |
3 Month Change | 18.14% |
1 Year Change | 53.92% |
33 Year Change | -17.17% |
5 Year Change | 74.64% |
Change since IPO | 36,368.09% |
Recent News & Updates
Recent updates
ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Shareholder Returns
RMD | US Medical Equipment | US Market | |
---|---|---|---|
7D | 8.1% | 1.2% | 0.07% |
1Y | 53.9% | 12.1% | 22.7% |
Return vs Industry: RMD exceeded the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: RMD exceeded the US Market which returned 22.6% over the past year.
Price Volatility
RMD volatility | |
---|---|
RMD Average Weekly Movement | 5.8% |
Medical Equipment Industry Average Movement | 8.7% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RMD's share price has been volatile over the past 3 months.
Volatility Over Time: RMD's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
RMD fundamental statistics | |
---|---|
Market cap | US$36.00b |
Earnings (TTM) | US$1.02b |
Revenue (TTM) | US$4.69b |
35.3x
P/E Ratio7.7x
P/S RatioIs RMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RMD income statement (TTM) | |
---|---|
Revenue | US$4.69b |
Cost of Revenue | US$2.00b |
Gross Profit | US$2.69b |
Other Expenses | US$1.67b |
Earnings | US$1.02b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 6.95 |
Gross Margin | 57.38% |
Net Profit Margin | 21.79% |
Debt/Equity Ratio | 14.5% |
How did RMD perform over the long term?
See historical performance and comparison